Frank Boehm

 

Frank J Boehm comes from a diverse background that includes a 12-year stint as a full-time rock/pop musician in various bands that toured North America (1975–87) and 17 years as a senior mechanical designer involved in the design and development of dedicated robotic tooling for complex automated assembly systems (1987–2004). He has been further engaged as a nanotechnology consultant, technology scout, product designer, research associate, and academic writer/editor for several international corporations and university laboratories since 1996.

Frank has been involved with nanotechnology (especially nanomedicine) since 1996 (completely autodidactically trained), which inspired the development of numerous concepts and designs for advanced nanomedical diagnostic and therapeutic components, devices, and systems to potentially address myriad disease states. His aim is to develop and transform these concepts into real world applications for global benefit. He serendipitously encountered the concept of nanotechnology on the internet and immediately became fascinated with its virtually limitless potential, particularly as it relates to the medical domain. He passionately proceeded to evolve and textually articulate various advanced near-term and longer-term nanomedical concepts and designs.

Concomitantly, he initiated correspondence with numerous nanotechnology and nanomedicine research scientists and thought leaders from across the globe and founded a startup company, (NanoApps Medical, Inc. (2009)) with the aim of investigating and developing advanced, innovative, and cost-effective nanomedical diagnostic and therapeutic devices and systems for the benefit of humanity. Upon recognizing the immense potential of nanomedicine to impart positive paradigm shifts across the medical domain (e.g., via precisely targeted drug delivery, vascular/neurological/cellular plaque removal, eradication of cancers via hypothermic nanoparticles, completely non-invasive surgical procedures, the enhancement of physiological systems, and extended longevity) Frank was deeply motivated to write more extensively on the

topic. This culminated in the authoring/publication of his first book, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions(CRC Press, 2013).

Subsequently, he authored/co-authored numerous book chapters and journal articles, including an in-depth paper entitled ‘Human Brain/Cloud Interface’ (Frontiers in Neuroscience, 2019), and co-founded NanoApps Athletics, Inc. in the same year. Frank then set his focus on a far more expansive investigation into the possibilities of nanotechnology/nanomedicine coupled with AI/AGI/ASI and quantum computation via the simultaneous compilation of a set of three companion books (with multiple chapter contributors for each) that explore a trifecta of envisaged global-scale paradigm-shifting technology platforms: Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence (CRC Press, 2025), Molecular Manufacturing: The Future of Nanomedicine (CRC Press, 2025), and Nanomedical Brain/Cloud Interface: Explorations and Implications (IOP Publishing, 2025).

In 2024, together with Amanda Scott (CEO NanoApps Medical, Inc., Co-Founder Alias Group Creative) Frank initially began to explore the idea/possibility for the establishment of a nonprofit dedicated to the realization of the vision of Global Health Care Equivalency for the benefit of humanity.

Ernest Daddey

Ernest Daddey is an award-winning Materials Scientist, entrepreneur, and senior technology executive with more than 25 years of experience leading the commercialization of advanced engineering materials and manufacturing technologies. He has a proven record of transforming research-driven innovation into scalable, revenue-generating businesses, reducing technicaland market risk for investors and public funding partners.

Ernest specializes in the innovation-to-commercialization lifecycle, including applied R&D, product and process development, pilot manufacturing, quality systems (QMS), new product development and introduction (NPD/NPI), and global go-to-market execution. His work consistently delivers commercial traction, IP creation, capital attraction, and economic impact across multiple sectors including clean technology, advanced materials, digital sensing, energy, infrastructure, and industrial systems.

Ernest has held senior leadership and advisory roles including CEO, Chief Development Officer, Vice President of Technology Development, Chief Scientific Advisor, and CTO, supporting both startups and public companies. His experience spans Canada, the United States, Europe, the UK, Africa, and Japan, enabling effective execution across international supply chains, regulatory environments, and commercialization pathways.

As an inventor of six patents and multiple trademarks, Ernest strengthens project defensibility and long-term value creation. He is frequently engaged by companies and public-sector programs to de-risk technology development, accelerate time-to-market, and align innovation roadmaps with investor and government funding criteria. His leadership emphasizes capital efficiency, partnerships, and measurable outcomes, supporting sustainable growth and job creation.